Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Recruiting now

Conditions studied: Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart

In brief

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Key facts

Study ID

NCT07224906

Run by

HemoCept Inc.

People needed

50

Starts

2025-12-01

Expected to finish

2027-01-01

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
• Subjects can be any gender but must be age 18 or older.
• Subject is able and willing to provide informed consent and HIPAA authorization.
• Subject is able and willing to meet all study requirements.
• Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

You may not qualify if…

• Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Where it is running

• Boulder Heart — Boulder, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.